These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24747591)
21. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma. Diao ZB; Sun TX; Zong Y; Lin BC; Xia YS J Int Med Res; 2020 Dec; 48(12):300060520967818. PubMed ID: 33284712 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma. Tang J; Zhao H; Cai H; Wu H Biomed Pharmacother; 2015 Apr; 71():222-6. PubMed ID: 25960240 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma. Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma. Lian H; Zhou Y; Sun Z; Liu K Medicine (Baltimore); 2022 Sep; 101(38):e30722. PubMed ID: 36197268 [TBL] [Abstract][Full Text] [Related]
25. miR-21 predicts poor prognosis in patients with osteosarcoma. Ren X; Shen Y; Zheng S; Liu J; Jiang X Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432 [TBL] [Abstract][Full Text] [Related]
26. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma. Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539 [TBL] [Abstract][Full Text] [Related]
27. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma. Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431 [TBL] [Abstract][Full Text] [Related]
28. Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients. Shi L; Xie C; Zhu J; Chen X Ann Diagn Pathol; 2020 Jun; 46():151488. PubMed ID: 32172218 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients: An observational study. Xie XY; Chen XM; Shi L; Liu JW Medicine (Baltimore); 2021 Mar; 100(12):e24765. PubMed ID: 33761638 [TBL] [Abstract][Full Text] [Related]
30. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. Liu W; Zhao ZY; Shi L; Yuan WD Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657 [TBL] [Abstract][Full Text] [Related]
31. Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma. Ma W; Zhang X; Chai J; Chen P; Ren P; Gong M Tumour Biol; 2014 Dec; 35(12):12467-72. PubMed ID: 25185654 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma. Maruyama T; Nishihara K; Umikawa M; Arasaki A; Nakasone T; Nimura F; Matayoshi A; Takei K; Nakachi S; Kariya KI; Yoshimi N Oncol Lett; 2018 Feb; 15(2):2349-2363. PubMed ID: 29434944 [TBL] [Abstract][Full Text] [Related]
33. Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. Cai H; Lin L; Cai H; Tang M; Wang Z Med Oncol; 2013 Jun; 30(2):499. PubMed ID: 23430441 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma. Lian D; Wang ZZ; Liu NS Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944 [TBL] [Abstract][Full Text] [Related]
35. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma. Wang T; Ji F; Dai Z; Xie Y; Yuan D Cancer Biomark; 2015; 15(5):543-50. PubMed ID: 26406942 [TBL] [Abstract][Full Text] [Related]
36. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma. Yuan J; Chen L; Chen X; Sun W; Zhou X J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer. Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267 [TBL] [Abstract][Full Text] [Related]
38. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma. Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma. Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]